Healthcare
Live Price
Offline$3.72
+2.76% today
1Y Change
+23.47%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Voyager Therapeutics, Inc. (VYGR) is a Healthcare stock with a market cap of $230.00M and listed on NASDAQ. The stock last traded around $3.72 and up 23.5% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -49.5%, EPS growth of -80.5%, a dividend yield of 0.0%. What stands out right now is revenue -49.5%, EPS -80.5%, free cash flow -617.2% with operating margin -326.6% and ROIC -56.4%. Valuation sits in the middle of the pack at price/sales 5.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VYGR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VYGR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VYGR Max Drawdown
-37.71%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VYGR and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.